A Randomized Comparative Effectiveness Study of Staged Complete Revascularization with Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients with Symptomatic Aortic Valve Stenosis undergoing Elective

Brief description of study

The purpose of this study is to find out, in patients with coronary artery disease (CAD) who had successful transcatheter aortic valve replacement (TAVR) with a balloon expandable heart valve, whether restoring blood flow to all blocked or narrowed arteries via percutaneous coronary intervention (PCI) using coronary stents (metal scaffold) is better than treating the coronary artery disease with medications only following TAVR. The study will also compare measurements of hemodynamics (blood flow and blood pressure) that are taken during on-table procedures (TAVR and PCI) with those taken by echocardiography (heart ultrasound). These measurements are all taken as a part of standard practice for TAVR patients at NYU Langone – Long Island.

Clinical Study Identifier: s21-00307
ClinicalTrials.gov Identifier: NCT04634240
Principal Investigator: Richard K Schwartz.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.